Physician profile
Namir Katkhouda
NPI 1164450714
$187,332.44
in general payments reported to CMS, 2019-2025
10 companies · $49K in 2025
The $49K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74K · 2020: $9,937 · 2022: $7,713 · 2023: $46K · 2025: $49K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $61K · Consulting Fee: $18K · Travel and Lodging: $13K · Food and Beverage: $2,788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $60,652.57 |
| Consulting Fee | $18,373.12 |
| Travel and Lodging | $13,394.31 |
| Food and Beverage | $2,787.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $102,887.52 | 2022-2025 | Signia, Progrip, Transorb |
| Covidien LP | $50,667.50 | 2019-2020 | |
| Davol INC. | $15,749.39 | 2019-2020 | |
| Baxter Healthcare | $15,491.89 | 2019 | |
| Ethicon INC. | $1,620.00 | 2019 | |
| Stryker Corporation | $565.98 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $130.90 | 2020 | |
| Karl Storz Endoscopy-America | $101.91 | 2019 | |
| Intuitive Surgical, INC. | $84.06 | 2019 | |
| Tela Bio, INC. | $33.29 | 2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Namir Katkhouda listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.